ADMA Biologics
ADMA
#4946
Rank
S$2.60 B
Marketcap
S$11.62
Share price
1.79%
Change (1 day)
-44.00%
Change (1 year)

Market capitalization of ADMA Biologics (ADMA)

Market cap: S$2.60 Billion

As of September 2026 ADMA Biologics has a market cap of S$2.60 Billion. This makes ADMA Biologics the world's 4946th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ADMA Biologics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026S$2.60 B-55.93%
2025S$5.90 B5.35%
2024S$5.60 B315.66%
2023S$1.34 B17.4%
2022S$1.14 B207.84%
2021S$0.37 B53.03%
2020S$0.24 B-23.75%
2019S$0.31 B111.37%
2018S$0.15 B-22.21%
2017S$0.19 B103.74%
2016S$95.49 M-21.91%
2015S$0.12 B-10.83%
2014S$0.13 B49.35%
2013S$91.82 M

End of Day market cap according to different sources

On Sep 18th, 2026 the market cap of ADMA Biologics was reported to be:

S$2.60 Billion
by Nasdaq info icon info icon
S$2.60 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Repligen
RGEN
S$12.73 B 389.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
S$2.12 B-18.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
S$37.24 M-98.57%๐Ÿ‡บ๐Ÿ‡ธ USA